ZOLL Ventilating Apparatus Patent Publication

The European Patent Office published patent application EP4493244A1 for ZOLL Medical Corporation covering an apparatus for ventilating a patient or treating respiratory distress. The patent lists 12 inventors and covers IPC classifications A61M 16/00, A61M 16/08, and A61M 16/20. The application designates all relevant EPO member states.

Medical Liquid Detection Sheet

The European Patent Office published patent EP4461325A1 for Nipro Corporation's medical liquid detection sheet technology. The patent application was published March 25, 2026, with inventors YAMABE Kohei and MATSUBAYASHI Satsuki. The patent is designated for all European Patent Convention member states including DE, FR, GB, IT, NL, and 25 other countries.

Medical Syringe with Filtering Needle Cap

EPO published patent application EP4633696A1 for Becton, Dickinson and Company's medical syringe with filtering needle cap. The invention by inventors Nalawade, Prasad, and Kumar is classified under IPC A61M (medical devices) and covers syringe designs with integrated filtration technology. No regulatory compliance deadlines or penalties apply to this patent publication.

Peanut Oral Immunotherapy Maintenance Dose Patent

The European Patent Office published patent EP3836801A1 granted to Société des Produits Nestlé S.A. for peanut oral immunotherapy with a maintenance dose. The patent covers compositions and methods for treating peanut allergies using immunotherapy. Inventors include Daniel Adelman.

Compositions and Methods Involving Transforming Extracellular Vesicles

The European Patent Office published patent EP3826603A1 granted to Mayo Foundation for Medical Education and Research. The patent covers compositions and methods involving transforming extracellular vesicles, with designated states across EU member states and other European jurisdictions.

Bone Scaffold Implant Patent Application

The European Patent Office published patent application EP4551159A1 for an osteopore bone scaffold implant developed by Osteopore International Pte. Ltd. and Queensland University of Technology. The invention is classified under A61F 2/28 (bone/bone substitute implants) and A61F 2/30 (joint prosthetics). The application designates all EPC contracting states including EU member states, Switzerland, Norway, and Turkey.

Acetabular cup separator for artificial hip joint surgery

The European Patent Office published patent application EP4523663A1 filed by IMEDICOM Co., Ltd. covering an acetabular cup separator device for artificial hip joint surgery. The invention classifies under IPC A61F 2/46 (prostheses for bone joints) and A61F 2/34 (bone socket prostheses) with inventors JU Don Soo, LEE Byoung Ju, and KIM Tae San. The patent is designated for all 44 European Patent Convention contracting states.

Gastroenteroanastomosis Device Patent by Geabetes ApS

The European Patent Office published patent application EP4633484A1 for a gastroenteroanastomosis device filed by Danish company Geabetes ApS. The patent covers surgical instruments and methods for creating anastomoses between the gastrointestinal tract and other organs. The application lists six inventors including researchers PETERSEN, KJELDSEN, HARBOE, TOFT, VILMANN, and SAFTOIU.

Valve Prosthesis Patent - RWTH Aachen University

The European Patent Office published patent application EP4633535A1 for RWTH Aachen University covering a minimally invasive implantable valve prosthesis and valve stent for connecting artificial valve leaflets. Thomas Schmitz-Rode is listed as inventor. The patent application was published March 25, 2026, with designation extending to all EU member states and EPC contracting states.

Method for Purifying 226Ra-Containing Solution and Producing 225Ac Cancer Therapy

The European Patent Office published patent application EP3996111A1 for Nihon Medi-Physics Co., Ltd., covering methods for purifying radium-226 containing solutions and producing actinium-225 for cancer therapy. The patent addresses radiopharmaceutical manufacturing processes for targeted alpha therapy. No regulatory compliance obligations are imposed by this publication notice.